Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Ethanol-Lock Therapy for Prevention of CLABSI in Pediatric Patients
NCT03253887Phase 3Completed
- Sponsor
- IMIP
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ethanol in catheter-related bloodstream infection (CRBSI) (2 arms), sponsored by IMIP. Primary endpoint: Number of central line associated bloodstream infection (CLABSI) episodes. Started Mar 2016; status: completed.
02
Drugs
ethanol
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT03253887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03253887.